CDP-Choline
Research Reliability -
A dual-action brain nutrient that supplies both choline and cytidine to support neurotransmitter synthesis and mental sharpness.
Appetite
Mood
Sleep
CDP-Choline
Description
CDP-Choline (citicoline) is unique among choline sources because it breaks down into both choline and cytidine in the body, the latter of which converts to uridine, a key building block of neural membranes and an enhancer of dopamine signaling. Sold under the trade name Cognizin, this highly purified form has been studied extensively for its ability to improve attention, verbal memory, and overall cognitive function. It supports the synthesis of acetylcholine and phosphatidylcholine while also providing neuroprotective effects. A premium option for those seeking both immediate cognitive enhancement and long-term brain health support.
Effects
First dose
steadier focus and mental energy within an hour
Same day
good for deep-work sessions
Weeks 2–4
sustained attention and memory support builds
How it Feels
Cleaner and calmer than a stimulant, with a noticeable lift in focus and mental stamina within the hour for most people. It tends not to cause jitters. The effect is felt but understated, more clarity than energy.
Usage
Entry Dose
125mg
Standard Dose
250–500mg
Max Dose
1000mg
Onset
30–60 min (acute); 2–4 weeks (sustained)
Combinations
Pairs well with
Synergistic
Alpha-GPC — stack at lower doses of each for synergistic choline delivery
Uridine monophosphate — CDP-choline breaks down to cytidine (→uridine); uridine amplifies effect
DHA — uridine + choline + DHA is the Kennedy pathway brain membrane triad
Avoid combining
Contraindicated
Anticholinergic medications — CDP-choline opposes drugs that block acetylcholine
High-dose alpha-GPC simultaneously — excess choline can cause headache, brain fog, and lethargy
Biomarkers to Track
Subjective
(Daily)
Mental focus and clarity (1–10)
Memory recall and retention
Motivation and drive score
Objective
(Quarterly)
Cognitive assessment score
Salivary cortisol AM level
HRV baseline score
Very safe and well studied, with a clean tolerability record.
Few people need to avoid it.
Taking it late in the day (it is mildly activating) and expecting stimulant-like energy.
Moderate (some human RCTs)
This trial used the specific branded Cognizin ingredient at 250-500mg; results may not generalize to generic, unstandardized citicoline products.
McGlade E et al. (2012). Food and Nutrition Sciences, 3, 769-773. RCT (branded Cognizin citicoline, attention in healthy women).